Total Funding
75
55
Total FundingSeries A raised
Growth Score
-3 pts
Heat Score
34 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
5052
Predicta Biosciences provides molecular diagnostics and immunotherapeutic discovery services for hematological diseases.
- Romanos Sklavenitis-Pistofidis: Co-Founder
- Irene Ghobrial: Co-Founder
About the Company
Predicta Biosciences delivers molecular diagnostics, artificial intelligence tools, and immunotherapeutic discovery services for hematological diseases. It operates a platform that uses whole-genome sequencing of bone marrow biopsies and circulating tumor cells to replace conventional assays and support high-resolution disease monitoring. The
company complements genomic data with multiomic immune profiling to inform personalized therapy decisions. Its AI/ML engine mines a growing patient database to uncover novel therapeutic targets. Its focus includes diagnostics across patient disease progression and internal immunotherapy development.
